ロード中...
Do NOACs Improve Antithrombotic Therapy in Secondary Stroke Prevention in Nonvalvular Atrial Fibrillation?
Guidelines recommended oral anticoagulant (OAC) for ischemic stroke patients related to atrial fibrillation (AF). But, underprescription or underdose of warfarin was observed worldwide. We aimed to explore if the use of antithrombotic therapy in nonvalvular AF (NVAF) ischemic stroke patients improve...
保存先:
| 出版年: | Medicine (Baltimore) |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wolters Kluwer Health
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4635774/ https://ncbi.nlm.nih.gov/pubmed/26402834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000001627 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|